Based on evidence from inflammatory responses in the airways and vasculature and autoimmune complications in humans and rodents, it is beyond doubt that hepatocellular inflammation such as that seen in NASH can result from the activation of purinergic receptors. This evidence concerns the gene P2RX7 and metabolic dysfunction-associated steatohepatitis.